Does thrombocyte size give us an idea about thrombocytosis etiology?

The Scientific World Journal

Volumn 2012, Issue , 2012, Pages

  Toprak, Selami Kocak ^a   Erismis, Betul ^a   Karakus, Sema ^a   Kursun, Nazmiye ^b   Haberal, Aysegul ^a   Ulusoy, Mustafa Gurhan ^c  

^a BASKENT UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN; IRON; JAK2 PROTEIN, HUMAN; JANUS KINASE 2;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE MARKER; ERYTHROCYTE; ERYTHROCYTE COUNT; FEMALE; HETEROZYGOTE; HUMAN; HUMAN CELL; IRON BLOOD LEVEL; LEUKOCYTE; MALE; MEDICAL RECORD REVIEW; PATHOGENESIS; PREDICTIVE VALUE; REACTIVE THROMBOCYTOSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; THROMBOCYTE; THROMBOCYTE VOLUME; THROMBOCYTHEMIA; THROMBOCYTOSIS; CELL SIZE; GENETICS; MIDDLE AGED; MUTATION; PATHOLOGY; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PLATELETS; CELL SIZE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMOGLOBINS; HETEROZYGOTE; HUMANS; JANUS KINASE 2; MALE; MIDDLE AGED; MUTATION; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; ROC CURVE; THROMBOCYTOSIS;

EID: 84867818128     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/598653     Document Type: Article

References (18)

1. Kaushansky K., The molecular mechanisms that control thrombopoiesis. Journal of Clinical Investigation 2005 115 12 3339 3347 2-s2.0-31044439372 10.1172/JCI26674 (Pubitemid 43121817)
2. Kaushansky K., Kaushansky K., Lichtman M. A., Beutler E., Reactive thrombocytosis. Williams Hematology 2010 8th New York, NY, USA McGraw-Hill 1929 1932
3. Beer P. A., Erber W. N., Campbell P. J., Green A. R., How I treat essential thrombocythemia. Blood 2011 117 5 1472 1482 2-s2.0-79551631692 10.1182/blood-2010-08-270033
4. Tefferi A., Vardiman J. W., Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008 22 1 14 22 2-s2.0-38349101871 10.1038/sj.leu.2404955
5. Beutler E., Kaushansky K., Lichtman M. A., Beutler E., Disorders of iron metabolism. Williams Hematology 2010 8th New York, NY, USA McGraw-Hill 565 606
6. Osselaer J. C., Jamart J., Scheiff J. M., Platelet distribution width for differential diagnosis of thrombocytosis. Clinical Chemistry 1997 43 6 1072 1076 2-s2.0-0030913167 (Pubitemid 27247002)
7. Sehayek E., Ben-Yosef N., Modan M., Chetrit A., Meytes D., Platelet parameters and aggregation in essential and reactive thrombocytosis. American Journal of Clinical Pathology 1988 90 4 431 436 2-s2.0-0023749221
8. Small B. M., Bettigole R. E., Diagnosis of myeloproliferative disease by analysis of the platelet volume distribution. American Journal of Clinical Pathology 1981 76 5 685 691 2-s2.0-0019518928 (Pubitemid 11026274)
9. Miller J. L., Henry J. B., Blood platelets. Clinical Diagnosis and Management by Laboratory Methods 2001 20th Philadelphia, Pa, USA Saunders 632 641
10. Graham S. S., Traub B., Mink I. B., Automated platelet-sizing parameters on a normal population. American Journal of Clinical Pathology 1987 87 3 365 369 2-s2.0-0023127226 (Pubitemid 17046987)
11. Bessman J. D., The relation of megakaryocyte ploidy to platelet volume. American Journal of Hematology 1984 16 2 161 170 2-s2.0-0021343562 (Pubitemid 14184639)
12. Van Der Lelie J., Von Dem Borne A. K. R., Platelet volume analysis for differential diagnosis of thrombocytosis. Journal of Clinical Pathology 1986 39 2 129 133 2-s2.0-0022651429 (Pubitemid 16144966)
13. Levin J., Bessman J. D., The inverse relation between platelet volume and platelet number. Abnormalities in hematologic disease and evidence that platelet size does not correlate with platelet age. Journal of Laboratory and Clinical Medicine 1983 101 2 295 307 2-s2.0-0020662352 (Pubitemid 13152011)
14. Hu G. Y., Deng M. Y., Zhang G. S., Luo Y. Y., Zhu J. F., The frequency of JAK2 V617F mutation, expression level of phosphorylated JAK/STATs proteins and their clinical significance in myeloproliferative disorders patients. Zhonghua Xue Ye Xue Za Zhi 2009 30 6 394 398 2-s2.0-79958266626
15. Heller P. G., Lev P. R., Salim J. P., Kornblihtt L. I., Goette N. P., Chazarreta C. D., Glembotsky A. C., Vassallu P. S., Marta R. F., Molinas F. C., JAK2V617F mutation in platelets from essential thrombocythemia patients: correlation with clinical features and analysis of STAT5 phosphorylation status. European Journal of Haematology 2006 77 3 210 216 2-s2.0-33746858555 10.1111/j.1600-0609.2006.00688.x (Pubitemid 44181383)
16. Randi M. L., Ruzzon E., Tezza F., Scapin M., Duner E., Scandellari R., Fabris F., JAK2V617F mutation is common in old patients with polycythemia vera and essential thrombocythemia. Aging 2011 23 1 17 21 2-s2.0-79956299123
17. Abdulkarim K., Ridell B., Johansson P., Kutti J., Safai-Kutti S., Andréasson B., The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera. European Journal of Haematology 2011 86 2 148 155 2-s2.0-78651456842 10.1111/j.1600-0609.2010.01548.x
18. Carobbio A., Antonioli E., Guglielmelli P., Vannucchi A. M., Delaini F., Guerini V., Finazzi G., Rambaldi A., Barbui T., Leukocytosis and risk stratification assessment in essential thrombocythemia. Journal of Clinical Oncology 2008 26 16 2732 2736 2-s2.0-45749098579 10.1200/JCO.2007.15.3569